Literature DB >> 21723701

Modern total hip arthroplasty in patients younger than 21 years.

Atul F Kamath1, Neil P Sheth, Harish H Hosalkar, Oladapo M Babatunde, Gwo-Chin Lee, Charles L Nelson.   

Abstract

Total hip arthroplasty (THA) is not commonly performed in adolescents. However, it may be the only option for pain control with continued mobility for advanced disease. We report our experience with modern alternative-bearing THA in patients younger than 21 years. Twenty-one THAs (18 patients) were followed. Preoperative and postoperative Harris hip scores were recorded, and radiographs were reviewed. Average follow-up was 49 months (range, 25-89). Underlying etiology was chemotherapy-induced osteonecrosis (33%), steroid-induced osteonecrosis (29%), sickle cell disease (24%), and chronic dislocation (14%). Articulation bearings were ceramic/ceramic (67%), metal/highly cross-linked polyethylene (29%), and metal resurfacing (5%). Mean age was 18 years (range, 13-20). Harris hip scores improved from 43.6 to 83.6 (P < .001). At final follow-up, there was no radiographic loosening; 1 THA was revised for a cracked ceramic liner. At intermediate-term follow-up, clinical and radiographic results are favorable after alternative-bearing THA in patients younger than 21 years. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21723701     DOI: 10.1016/j.arth.2011.04.042

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  14 in total

1.  Survivorship of hip and knee implants in pediatric and young adult populations: analysis of registry and published data.

Authors:  Art Sedrakyan; Lucas Romero; Stephen Graves; David Davidson; Richard de Steiger; Peter Lewis; Michael Solomon; Robyn Vial; Michelle Lorimer
Journal:  J Bone Joint Surg Am       Date:  2014-12-17       Impact factor: 5.284

Review 2.  Has total hip arthroplasty in patients 30 years or younger improved? A systematic review.

Authors:  Muyibat A Adelani; James A Keeney; Allison Palisch; Susan A Fowler; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2013-04-06       Impact factor: 4.176

Review 3.  Current concepts in the treatment of adolescent femoroacetabular impingement.

Authors:  Manoj Ramachandran; Shin Azegami; Harish S Hosalkar
Journal:  J Child Orthop       Date:  2013-01-11       Impact factor: 1.548

4.  The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Authors:  Courtney D Fitzhugh; Mark C Walters
Journal:  Blood Adv       Date:  2017-12-08

5.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

6.  Evaluation of clinical outcomes of cementless total hip arthroplasty in patients under 30 years of age.

Authors:  Mohsen Mardani-Kivi; Mahmoud Karimi-Mobarakeh; Kamran Asadi; Keyvan Hashemi-Motlagh; Khashayar Saheb-Ekhtiari
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-27

7.  Long Term Outcomes of Total Hip Arthroplasty in Young Patients under 30.

Authors:  Emilios E Pakos; Nikolaos K Paschos; Theodoros A Xenakis
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

Review 8.  Evolution of total hip arthroplasty in patients younger than 30 years of age: A systematic review and meta-analysis.

Authors:  Andrew Konopitski; Chielozor Okafor; Brendan Smith; Keith Baldwin; Neil P Sheth
Journal:  Arch Orthop Trauma Surg       Date:  2022-02-07       Impact factor: 3.067

Review 9.  Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.

Authors:  Mariël L Te Winkel; Rob Pieters; Ernst-Jan D Wind; J H J M Gert Bessems; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

Review 10.  Fracture of ceramic bearing surfaces following total hip replacement: a systematic review.

Authors:  Francesco Traina; Marcello De Fine; Alberto Di Martino; Cesare Faldini
Journal:  Biomed Res Int       Date:  2013-06-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.